The willingness of patients to accept an additional mortality risk in order to improve renal graft survival.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Kidney International

• Publication date

  2004-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/J.1523-1755.2004.00740.XPMID 15200446
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [De novo malignant tumors during drug immunosuppression. The findings following 1245 cadaveric kidney transplants in 1080 patients].

  2008cited by this paper
• Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients.

  2002cited by this paper
• Effects of changing immunosuppressive regimen on the incidence, duration, and viral load of cytomegalovirus infection in renal transplantation: a single center report

  2002cited by this paper
• Health profiles and health preferences of dialysis patients.

  2002cited by this paper
• Maintenance immunosuppression in the renal transplant recipient: an overview.

  2001cited by this paper
• Overview of clinical trials with new agents.

  2001cited by this paper
• The repeatability of three methods for measuring prospective patients' values in the context of treatment choice for end-stage renal disease.

  1999cited by this paper
• Time-tradeoff Values and Standard-gamble Utilities Assessed during Telephone Interviews versus Face-to-face Interviews

  1998cited by this paper
• Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens.

  1998cited by this paper
• Estimating General-population Utilities Using One Binary-gamble Question per Respondent

  1998cited by this paper
• Measurement of the validity of utility elicitations performed by computerized interview.

  1997cited by this paper
• Incidence of cytomegalovirus infection in kidney recipients.

  1996cited by this paper
• EFFECT OF OKT3 IN STEROID‐RESISTANT RENAL TRANSPLANT REJECTION

  1995cited by this paper
• Side-effects of a monoclonal antibody, muromonab CD3/orthoclone OKT3: bibliographic review.

  1995cited by this paper
• Skin cancer and warts in immunosuppressed renal transplant recipients.

  1995cited by this paper
• Causes of death in renal transplant recipients: a study of 102 autopsies from 1968 to 1991.

  1995cited by this paper
• Morbidity after renal transplantation: role of bacterial infection.

  1995cited by this paper
• Evaluation of infections in renal transplant recipients treated with cyclosporine.

  1994cited by this paper
• Infectious complications in solid organ transplant recipients.

  1994cited by this paper
• OKT3 rescue for steroid-resistant rejection in adult liver transplantation.

  1993cited by this paper
• Lymphoproliferative disorders after renal transplantation in patients receiving triple or quadruple immunosuppression.

  1992cited by this paper
• A randomized prospective comparison of MALG with OKT3 for rescue therapy of acute myocardial rejection.

  1991cited by this paper
• Measuring patient preferences for health outcomes: a decision analytic approach.

  1989influential reference
• Methodology for measuring health-state preferences--II: Scaling methods.

  1989influential reference
• A comparison of OKT3 monoclonal antibody and corticosteroids in the treatment of acute renal allograft rejection.

  1988cited by this paper
• Tumors of the immunocompromised patient.

  1988cited by this paper
• Measurement of quality of life in end-stage renal disease: the time trade-off approach.

  1987cited by this paper
• A RANDOMIZED CLINICAL TRIAL COMPARING OKT3 AND STEROIDS FOR TREATMENT OF HEPATIC ALLOGRAFT REJECTION

  1987cited by this paper
• Utility approach to measuring health-related quality of life.

  1987cited by this paper
• Discussion: Torrance's “utility approach to measuring health-related quality of life”

  1987cited by this paper
• Statistical methods for assessing agreement between two methods of clinical measurement.

  1986cited by this paper
• Measurement of health state utilities for economic appraisal.

  1986cited by this paper
• Teaching Clinical Decision Making

  1985cited by this paper
• Preferences for Health Outcomes

  1984cited by this paper
• On the elicitation of preferences for alternative therapies.

  1982cited by this paper
• The framing of decisions and the psychology of choice.

  1981cited by this paper
• Social preferences for health states: An empirical evaluation of three measurement techniques

  1976cited by this paper
• A utility maximization model for evaluation of health care programs.

  1972cited by this paper
• AKUFO AND IBARAPA.

  1965cited by this paper

• Global prevalence and potential factors influencing willingness for renal transplantation in end-stage renal disease patients: A systematic review and meta- analysis

  2024cites this paper
• Optimal threshold estimator of a prognostic marker by maximizing a time-dependent expected utility function for a patient-centered stratified medicine

  2018cites this paper
• Patient Preferences for Outcomes After Kidney Transplantation: A Best-Worst Scaling Survey

  2017cites this paper
• Kidney transplant patients’ preferences and priorities for outcomes after transplantation

  2016influential citation
• Quel seuil de discrimination pour un test pronostique à des fins de médecine stratifiée ? Extension du principe de maximisation de l'utilité espérée au contexte pronostique avec données censurées

  2015cites this paper
• Quality of survey reporting in nephrology journals: a methodologic review.

  2014cites this paper
• Autoévaluations de l'article : Prise en charge psychologique en transplantation d'organes : quel accompagnement pour les patients ?

  2011cites this paper
• Prolonged Prophylaxis With Valganciclovir Is Cost Effective in Reducing Posttransplant Cytomegalovirus Disease Within the United States

  2010cites this paper
• The effectiveness and cost-effectiveness of methods of storing donated kidneys from deceased donors: a systematic review and economic model.

  2009cites this paper
• Protocols for TTO valuations of health states worse than dead: A literature review and framework for systematic analysis

  2008cites this paper
• A Mathematical Risk-Benefit Analysis of Composite Tissue Allotransplantation

  2007cites this paper